Magadan, Axl Rose L.
HRN: 18-98-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2023
CEFUROXIME 1.5GM (VIAL)
06/24/2023
07/01/2023
IVTT
750mg
Q8
ATP
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes